Insulin resistance, a fundamental hallmark of metabolic disorders such as type 2 diabetes (T2D), has long been a significant challenge in the field of endocrinology and drug development. At Ace Therapeutics, we are dedicated to developing high-quality in vitro insulin resistance models that enable researchers to explore new frontiers in diabetes research.